Literature DB >> 27357674

Antibodies in multiple sclerosis oligoclonal bands target debris.

Ryan C Winger1, Scott S Zamvil2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27357674      PMCID： PMC4948325          DOI： 10.1073/pnas.1609246113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

2.  Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.

Authors:  Kevin Blauth; John Soltys; Adeline Matschulat; Cory R Reiter; Alanna Ritchie; Nicholas L Baird; Jeffrey L Bennett; Gregory P Owens
Journal:  Acta Neuropathol       Date:  2015-10-28       Impact factor: 17.088

3.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Authors:  Simone M Brändle; Birgit Obermeier; Makbule Senel; Jessica Bruder; Reinhard Mentele; Mohsen Khademi; Tomas Olsson; Hayrettin Tumani; Wolfgang Kristoferitsch; Friedrich Lottspeich; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

4.  Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.

Authors:  K G Porter; D G Sinnamon; R R Gillies
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

5.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

6.  Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid.

Authors:  H Link; S Baig; O Olsson; Y P Jiang; B Höjeberg; T Olsson
Journal:  J Neuroimmunol       Date:  1990-08       Impact factor: 3.478

7.  Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  K Hansen; M Cruz; H Link
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.

Authors:  Hans-Christian von Büdingen; Melanie D Harrer; Sandra Kuenzle; Mirjam Meier; Norbert Goebels
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

9.  Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.

Authors:  B G Xiao; C Linington; H Link
Journal:  J Neuroimmunol       Date:  1991-02       Impact factor: 3.478

Review 10.  Infectious causes of multiple sclerosis.

Authors:  Donald H Gilden
Journal:  Lancet Neurol       Date:  2005-03       Impact factor: 44.182
View more
  13 in total

1.  Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

Authors:  Jacqueline R Rivas; Sara J Ireland; Rati Chkheidze; William H Rounds; Joseph Lim; Jordan Johnson; Denise M O Ramirez; Ann J Ligocki; Ding Chen; Alyssa A Guzman; Mark Woodhall; Patrick C Wilson; Eric Meffre; Charles White; Benjamin M Greenberg; Patrick Waters; Lindsay G Cowell; Ann M Stowe; Nancy L Monson
Journal:  Acta Neuropathol       Date:  2016-10-11       Impact factor: 17.088

Review 2.  The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.

Authors:  Rui Li; Amit Bar-Or
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 3.  Multiple Sclerosis: B Cells Take Center Stage.

Authors:  Anne-Katrin Pröbstel; Stephen L Hauser
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

Review 4.  The role of B cells in the immunopathogenesis of multiple sclerosis.

Authors:  Tohid Gharibi; Zohreh Babaloo; Arezoo Hosseini; Faroogh Marofi; Abbas Ebrahimi-Kalan; Saeed Jahandideh; Behzad Baradaran
Journal:  Immunology       Date:  2020-05-10       Impact factor: 7.397

Review 5.  Alcohol and multiple sclerosis: an immune system-based review.

Authors:  Maryam Fahim; Aryan Rafiee Zadeh; Pouria Shoureshi; Keyvan Ghadimi; Masoumeh Cheshmavar; Neda Sheikhinia; Mahdieh Afzali
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-04-15

Review 6.  Multiple Sclerosis: Immunopathology and Treatment Update.

Authors:  Narges Dargahi; Maria Katsara; Theodore Tselios; Maria-Eleni Androutsou; Maximilian de Courten; John Matsoukas; Vasso Apostolopoulos
Journal:  Brain Sci       Date:  2017-07-07

Review 7.  The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models.

Authors:  Cole D Libner; Hannah E Salapa; Michael C Levin
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

8.  Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation.

Authors:  Raymond A Sobel; Mary Jane Eaton; Prajakta Dilip Jaju; Eugene Lowry; Julian R Hinojoza
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

Review 9.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

10.  Inhibition of Bruton's tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.

Authors:  Sebastian Torke; Roxanne Pretzsch; Darius Häusler; Philipp Haselmayer; Roland Grenningloh; Ursula Boschert; Wolfgang Brück; Martin S Weber
Journal:  Acta Neuropathol       Date:  2020-08-06       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.